Taysha Gene Therapies
TSHA
$2.67
Share price
0.75%
Change (1 day)
16.59%
Change (1 year)
Taysha Gene Therapies (TSHA) - Total assets
Total assets on the balance sheet as of March 2025 : $0.13 Billion USD
According to Taysha Gene Therapies's latest financial reports the company's total assets are $0.13 Billion USD. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Taysha Gene Therapies - Total assets on balance sheet (from 2020 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | $0.16 B | -7.16% |
| 2023-12-31 | $0.17 B | 36.79% |
| 2022-12-31 | $0.12 B | -40.98% |
| 2021-12-31 | $0.21 B | -17.35% |
| 2020-12-31 | $0.25 B | 1725773.33% |
| 2019-12-31 | $0.01 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.24 B | 75.52% | 🇺🇸 USA |